Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.

Kalungi S, Steine SJ, Wabinga H, Bostad L, Molven A.

BMC Clin Pathol. 2009 Aug 19;9:6. doi: 10.1186/1472-6890-9-6.

2.

Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.

Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A.

Clin Cancer Res. 1999 Dec;5(12):4065-72.

3.

Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.

De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A, Leoncini L.

Blood. 2007 Aug 15;110(4):1301-7. Epub 2007 May 7.

4.

Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.

Cinti C, Claudio PP, Howard CM, Neri LM, Fu Y, Leoncini L, Tosi GM, Maraldi NM, Giordano A.

Cancer Res. 2000 Jan 15;60(2):383-9.

5.

Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications.

Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G, Califano L, Leoncini L, Giordano A, Claudio PP.

Clin Cancer Res. 2005 May 1;11(9):3265-73.

6.

Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Cinti C, Leoncini L, Nyongo A, Ferrari F, Lazzi S, Bellan C, Vatti R, Zamparelli A, Cevenini G, Tosi GM, Claudio PP, Maraldi NM, Tosi P, Giordano A.

Am J Pathol. 2000 Mar;156(3):751-60.

7.

The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

J Pediatr Hematol Oncol. 2011 Mar;33(2):e54-9. doi: 10.1097/MPH.0b013e3181edf543.

PMID:
21127431
8.

Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.

Mileo AM, Mattarocci S, Matarrese P, Anticoli S, Abbruzzese C, Catone S, Sacco R, Paggi MG, Ruggieri A.

J Exp Clin Cancer Res. 2015 Nov 14;34:140. doi: 10.1186/s13046-015-0255-1.

9.

pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.

Moparthi SB, Bergman V, Adell G, Thorstensson S, Sun XF.

Int J Colorectal Dis. 2009 Nov;24(11):1303-10. doi: 10.1007/s00384-009-0767-2. Epub 2009 Jul 14.

PMID:
19597825
10.

Retinoblastoma-related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil.

Klumb CE, Magluta EP, Rezende LM, Apa AG, Alonso JF, Maia RC.

Am J Hematol. 2007 Mar;82(3):238-9.

11.

The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.

Masciullo V, Berardengo E, Boglione A, Sgambato A, Bernardi A, Forni M, Linari A, Cito L, Scambia G, Comandone A, Giordano A.

Clin Cancer Res. 2008 Aug 1;14(15):4775-9. doi: 10.1158/1078-0432.CCR-07-4055.

12.

Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis.

Lara MF, García-Escudero R, Ruiz S, Santos M, Moral M, Martínez-Cruz AB, Segrelles C, Lorz C, Paramio JM.

Mol Carcinog. 2008 Mar;47(3):209-21.

PMID:
17932948
13.

High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.

Priya K, Jada SR, Quah BL, Quah TC, Lai PS.

Cancer Biol Ther. 2009 Apr;8(8):714-7. Epub 2009 Apr 22.

PMID:
19252413
14.

Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy.

Giordano A, Rossi A, Romano G, Bagella L.

J Cell Physiol. 2007 Nov;213(2):403-6. Review.

PMID:
17708530
15.

pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer.

Cito L, Indovina P, Forte IM, Pentimalli F, Di Marzo D, Somma P, Barone D, Penon A, Penon D, Ceccherini E, Micheli P, Saragoni L, Di Domenico M, Feola A, Roviello F, Mattioli E, Giordano GG, Giordano A.

J Cell Physiol. 2015 Apr;230(4):802-5. doi: 10.1002/jcp.24805.

PMID:
25205458
16.

pRb2/p130: a gene target for diagnosis and treatment of cancer.

Coleman WB, Rivenbark AG.

Expert Opin Med Diagn. 2008 Oct;2(10):1197-203. doi: 10.1517/17530059.2.10.1197.

PMID:
23496428
17.

Retinoblastoma gene family expression in lymphoid tissues.

Leoncini L, Bellan C, De Falco G.

Oncogene. 2006 Aug 28;25(38):5309-14. Review.

PMID:
16936752
18.

pRb2/p130: a new candidate for retinoblastoma tumor formation.

De Falco G, Giordano A.

Oncogene. 2006 Aug 28;25(38):5333-40. Review.

PMID:
16936755
19.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
20.

Correlation of epidermal growth factor receptor mutation, immunohistochemistry, and fluorescence in situ hybridization in esophageal squamous cell carcinoma.

Sunpaweravong P, Suwiwat S, Sunpaweravong S, Puttawibul P, Mitarnun W.

J Med Assoc Thai. 2009 Sep;92(9):1136-42.

PMID:
19772171

Supplemental Content

Support Center